AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.10) per share. This is a 16.67 percent increase over losses of $(0.12) per share from the same period last year.
Cathie Wood’s Ark Invest Sells Tesla Shares Worth $15.9M, Bolsters Positions In Palantir By $14.9M
On Thursday, Ark Invest, under the leadership of Cathie Wood, executed significant transactions, including the sale of Tesla…